Skip to content

Italian Observational Study Assessing the Impact of Gout on Patients Disability and Quality of Life

Multicentre Prospective Observational Study for Identification of Determinants of Disability and Quality of Life in Patients With Gout.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01549210
Acronym
KING
Enrollment
450
Registered
2012-03-09
Start date
2011-04-30
Completion date
2013-03-31
Last updated
2013-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout

Keywords

gout, gouty arthritis

Brief summary

The study aims to identify which characteristics are associated with disability and poor quality of life in patients suffering from gout. This is a multicentre prospective observational study carried out in a cohort of Italian patients with gout. Subjects are randomly selected from a list of patients referred to each participant rheumatology clinic in the previous 2 years. Clinical evaluations are performed at baseline, at 6 and 12 months; data are retrieved about sociodemographic variables, life-styles, history of gout, comorbidities and patterns of treatment. At each visit patients complete questionnaires assessing disability and health-related quality of life. Preplanned analyses will be performed to investigate predictors of disability and poor quality of life in these patients.

Interventions

None listed

Sponsors

Italian Society for Rheumatology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of gout * Must be able to understand questionnaires

Exclusion criteria

* Diagnosis not validated by rheumatologist * Not able to sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Functional disability1 yearHealth Assessment Questionnaire Disability Index (HAQ-DI)

Secondary

MeasureTime frameDescription
Health-related quality of life1 yearShort Form-36 Physical Summary Scale (SF-36 PCS)

Other

MeasureTime frame
Short Form-36 Mental Summary Scale (SF-36 MCS)1 year
Serum uric acid levels6-12 months

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026